AAAAAA
Results: 26-50/378
Authors:
LOEBSTEIN R
KOREN G
Citation: R. Loebstein et G. Koren, IFOSFAMIDE-INDUCED NEPHROTOXICITY IN CHILDREN - CRITICAL-REVIEW OF PREDICTIVE RISK-FACTORS, Pediatrics, 101(6), 1998, pp. 81-84
Authors:
TADDIO A
OHLSSON A
EINARSON TR
STEVENS B
KOREN G
Citation: A. Taddio et al., A SYSTEMATIC REVIEW OF LIDOCAINE-PRILOCAINE CREAM (EMLA) IN THE TREATMENT OF ACUTE PAIN IN NEONATES, Pediatrics, 101(2), 1998, pp. 11-19
Authors:
PASTUSZAK AL
SCHULER L
SPECKMARTINS CE
COELHO KEFA
CORDELLO SM
VARGAS F
BRUNONI D
SCHWARZ IVD
LARRANDABURU M
SAFATTLE H
MELONI VFA
KOREN G
Citation: Al. Pastuszak et al., USE OF MISOPROSTOL DURING PREGNANCY AND MOBIUS-SYNDROME IN INFANTS, The New England journal of medicine, 338(26), 1998, pp. 1881-1885
Authors:
KOREN G
PASTUSZAK A
ITO S
Citation: G. Koren et al., DRUG-THERAPY - DRUGS IN PREGNANCY, The New England journal of medicine, 338(16), 1998, pp. 1128-1137
Authors:
SHUHAIBER S
PASTUSZAK A
SCHICK B
MATSUI D
SPIVEY G
BROCHU J
KOREN G
Citation: S. Shuhaiber et al., PREGNANCY OUTCOME FOLLOWING FIRST-TRIMESTER EXPOSURE TO SUMATRIPTAN, Neurology, 51(2), 1998, pp. 581-583
Authors:
LONDON B
JERON A
ZHOU J
BUCKETT P
HAN XG
MITCHELL GF
KOREN G
Citation: B. London et al., LONG QT AND VENTRICULAR ARRHYTHMIAS IN TRANSGENIC MICE EXPRESSING THEN-TERMINUS AND FIRST TRANSMEMBRANE SEGMENT OF A VOLTAGE-GATED POTASSIUM CHANNEL, Proceedings of the National Academy of Sciences of the United Statesof America, 95(6), 1998, pp. 2926-2931
Authors:
PASTRAKULJIC A
SCHWARTZ R
SIMONE C
DEREWLANY LO
KNIE B
KOREN G
Citation: A. Pastrakuljic et al., TRANSPLACENTAL TRANSFER AND BIOTRANSFORMATION STUDIES OF NICOTINE IN THE HUMAN PLACENTAL COTYLEDON PERFUSED IN-VITRO, Life sciences (1973), 63(26), 1998, pp. 2333-2342
Authors:
ITO S
WEITZMAN S
KLEIN J
GREENBERG M
LAU R
ATANAKOVIC G
KOREN G
Citation: S. Ito et al., LACK OF CISPLATIN-RANITIDINE KINETIC INTERACTIONS - IN-VIVO STUDY IN CHILDREN, AND IN-VITRO STUDY USING DOG RENAL BRUSH-BORDER MEMBRANE-VESICLES, Life sciences, 62(25), 1998, pp. 387-392
Authors:
DIAVCITRIN O
PARK YH
VEERASUNTHARAM G
POLACHEK H
BOLOGA M
PASTUSZAK A
KOREN G
Citation: O. Diavcitrin et al., THE SAFETY OF MESALAMINE IN HUMAN-PREGNANCY - A PROSPECTIVE CONTROLLED COHORT STUDY, Gastroenterology, 114(1), 1998, pp. 23-28
Authors:
KHATTAK S
KMOGHTADER G
MCMARTIN K
BARRERA M
KENNEDY D
KOREN G
Citation: S. Khattak et al., PREGNANCY OUTCOME FOLLOWING GESTATIONAL EXPOSURE TO ORGANIC-SOLVENTS - A PROSPECTIVE CONTROLLED-STUDY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 2-2
Authors:
LOEBSTEIN R
ADDIS A
HO E
DONNENFELD A
KOREN G
Citation: R. Loebstein et al., PREGNANCY OUTCOME FOLLOWING EXPOSURE TO FLUOROQUINOLONES (FQ) - MISPERCEPTION OF THE TERATOGENIC RISK, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 30-30
Authors:
ADDIS A
LOEBSTEIN R
KOREN G
EINARSON TR
Citation: A. Addis et al., METAANALYSIS OF THE CLINICAL EFFECTIVENESS OF ORAL DEFERIPRONE (L1), Clinical pharmacology and therapeutics, 63(2), 1998, pp. 68-68
Authors:
LALKIN A
LOEBSTEIN R
ADDIS A
KOREN G
Citation: A. Lalkin et al., SAFETY OF OMEPRAZOLE DURING PREGNANCY - A MULTICENTER PROSPECTIVE COHORT STUDY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 69-69
Authors:
DIAVCITRIN O
ATANACKOVIC G
KOREN G
Citation: O. Diavcitrin et al., CORRELATION BETWEEN INITIAL HEPATIC IRON CONCENTRATION AND RESPONSE TO DEFERIPRONE (L1) IN PATIENTS WITH BETA-THALASSEMIA MAJOR, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 77-77
Authors:
ITO S
WEITZMAN S
KLEIN J
GREENBERG M
LAU R
ATANAKOVIC G
KOREN G
Citation: S. Ito et al., LACK OF CISPLATIN-RANITIDINE INTERACTIONS IN CHILDREN, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 84-84
Authors:
KHATTAK S
ROGAN JW
BLOWEY D
ARBUS GS
KOREN G
Citation: S. Khattak et al., THE EFFECTIVENESS OF AMLODIPINE IN PEDIATRIC HYPERTENSION - A RANDOMIZED PROSPECTIVE, CROSSOVER TRIAL, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 88-88
Authors:
ESCOBAR MR
ITO S
KOREN G
Citation: Mr. Escobar et al., ORGANIC ION UPTAKE ALTERS CISPLATIN-INDUCED RENAL-CELL APOPTOSIS AND NECROSIS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 112-112
Authors:
WOODLAND C
ITO S
KLEIN J
CAMILLE G
WAINER I
KOREN G
Citation: C. Woodland et al., FIRST EVIDENCE OF RENAL BIOTRANSFORMATION OF IFOSFAMIDE TO NEPHROTOXIC METABOLITES, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 118-118
Authors:
ITO S
WOODLAND C
SARKADI B
WALKER SE
KOREN G
Citation: S. Ito et al., MODELING OF P-GLYCOPROTEIN-MEDIATED RENAL TUBULAR TRANSPORT OF DIGOXIN AND VINBLASTINE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 120-120
Authors:
KHATTAK S
ROGAN JW
SAUNDERS EF
THEIS JGW
ARBUS GS
KOREN G
Citation: S. Khattak et al., EFFICACY OF AMLODIPINE IN PEDIATRIC BONE-MARROW TRANSPLANT PATIENTS, Clinical pediatrics, 37(1), 1998, pp. 31-35
Authors:
ZHOU J
JERON A
LONDON B
HAN XQ
KOREN G
Citation: J. Zhou et al., CHARACTERIZATION OF A SLOWLY INACTIVATING OUTWARD CURRENT IN ADULT-MOUSE VENTRICULAR MYOCYTES, Circulation research, 83(8), 1998, pp. 806-814
Authors:
MURATA M
KOREN G
Citation: M. Murata et G. Koren, CLONING AND CHARACTERIZATION OF NOVEL PDZ-DOMAIN INCLUDING PROTEINS IN THE HEART, Circulation, 98(17), 1998, pp. 56-56
Authors:
MATHUR R
ZHOU J
BABILA T
KOREN G
Citation: R. Mathur et al., ASSEMBLY OF VOLTAGE-GATED POTASSIUM CHANNELS - CRITICALLY IMPORTANT RESIDUES IN THE FIRST TRANSMEMBRANE DOMAIN, Circulation, 98(17), 1998, pp. 1197-1197
Authors:
VALVERDE P
KOREN G
Citation: P. Valverde et G. Koren, PURIFICATION AND CHARACTERIZATION OF A KV1.5-REPRESSOR ELEMENT-BINDING FACTOR, Circulation, 98(17), 1998, pp. 2477-2477
Authors:
BAKER LC
CHOI BR
KOREN G
SALAMA G
Citation: Lc. Baker et al., OPTICAL MAPPING OF REENTRANT VT IN TRANSGENIC MICE, Circulation, 98(17), 1998, pp. 3902-3902